Ajanta Pharma has reported results for second quarter ended September 30, 2019.
The company has reported a rise of 15.95% in its net profit at Rs 120.70 crore for the quarter under review as compared to Rs 104.10 crore for the same quarter in the previous year. Total income of the company increased by 24.17% at Rs 598.76 crore for Q2FY20 as compared Rs 482.22 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 7.20% in its net profit at Rs 116.36 crore for the quarter under review as compared to Rs 125.39 crore for the same quarter in the previous year. However, total income of the company increased by 17.28% at Rs 655.98 crore for Q2FY20 as compared Rs 559.35 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1525.00 |
Dr. Reddys Lab | 5942.65 |
Cipla | 1345.35 |
Zydus Lifesciences | 925.95 |
Lupin | 1547.05 |
View more.. |